Literature DB >> 31914687

Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.

Zhiquan Liu1, Huanhuan Shan1, Siyu Chen1, Mao Chen1, Yuning Song1, Liangxue Lai1,2,3,4, Zhanjun Li1.   

Abstract

Base editors, composed of a cytidine deaminase or an evolved adenine deaminase fused to Cas9 nickase, enable efficient C-to-T or A-to-G conversion in various organisms. However, the NGG protospacer adjacent motif (PAM) requirement of Streptococcus pyogenes Cas9 (SpCas9) substantially limits the target sites suitable for base editing. Quite recently, a new engineered SpCas9-NG variant, which can recognize minimal NG PAMs more efficiently than the present xCas9 variant. Here, we investigated the efficiency and PAM compatibility of SpCas9-NG-assisted cytidine base editors (CBEs) and adenine base editors (ABEs) in rabbits. In this study, we showed that NG-BE4max and NG-ABEmax systems can achieve a targeted mutation efficiency of 75%-100% and 80%-100% with excellent PAM compatibility of NGN PAMs in rabbit embryos, respectively. In addition, both base editors were successfully applied to create new rabbit models with precise point mutations, demonstrating their high efficiency and expanded genome-targeting scope in rabbits. Meanwhile, NG-ABEmax can be used to precisely mimic human Hoxc13 p.Q271R missense mutation in Founder (F0) rabbits, which is arduous for conventional ABEs to achieve due to a NGA PAM requirement. Collectively, NG-BE4max and NG-ABEmax systems provide promising tools to perform efficient base editing with expanded targeting scope in rabbits and enhances its capacity to model human diseases.
© 2019 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  CRISPR/Cas9; NG PAMs; base editor; rabbit

Year:  2019        PMID: 31914687     DOI: 10.1096/fj.201901587R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide.

Authors:  Zhiquan Liu; Siyu Chen; Yingqi Jia; Huanhuan Shan; Mao Chen; Yuning Song; Liangxue Lai; Zhanjun Li
Journal:  Sci China Life Sci       Date:  2021-01-06       Impact factor: 6.038

Review 2.  New Directions in Pulmonary Gene Therapy.

Authors:  Amber Vu; Paul B McCray
Journal:  Hum Gene Ther       Date:  2020-09       Impact factor: 4.793

Review 3.  Genetically Modified Rabbits for Cardiovascular Research.

Authors:  Jianglin Fan; Yanli Wang; Y Eugene Chen
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

Review 4.  CRISPR base editing applications for identifying cancer-driving mutations.

Authors:  Martin Pal; Marco J Herold
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

5.  A Cas9-mediated adenosine transient reporter enables enrichment of ABE-targeted cells.

Authors:  Nicholas Brookhouser; Toan Nguyen; Stefan J Tekel; Kylie Standage-Beier; Xiao Wang; David A Brafman
Journal:  BMC Biol       Date:  2020-12-14       Impact factor: 7.431

6.  A synonymous mutation in IGF-1 impacts the transcription and translation process of gene expression.

Authors:  S Y Wang; Y Y Cheng; S C Liu; Y X Xu; Y Gao; C L Wang; Z G Wang; T Q Feng; G H Lu; J Song; P J Xia; L L Hao
Journal:  Mol Ther Nucleic Acids       Date:  2021-08-19       Impact factor: 8.886

7.  TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis.

Authors:  Yanbing Wang; Yiwu Chen; Chang Li; Zhiwei Xiao; Hongming Yuan; Yuanzhu Zhang; Daxin Pang; Xiaochun Tang; Mengjing Li; Hongsheng Ouyang
Journal:  Biology (Basel)       Date:  2022-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.